{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fpce.simplecast.com%2Fepisodes%2Fasco-2022-cll-sll-9xdgw0XQ","width":444,"version":"1.0","type":"rich","title":"ASCO 2022: Advances in CLL/SLL","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/86952976-b928-4317-884c-2c7ba3b2ae4d/7c767244-2bfe-404b-93a9-39b8269a695c/bcell-asco-cc-podcast-icon.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/7390564f-3899-4029-ae74-513b1fd94305\" height=\"200\" width=\"100%\" title=\"ASCO 2022: Advances in CLL/SLL\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Listen as John M. Burke, MD and Amy Esposito, FNP-C discuss some of the latest key data that may impact clinical practice for patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) reported at the American Society of Clinical Oncology (ASCO) 2022 Annual Conference"}